Related Experiment Video
Updated: May 9, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Challenges and future directions of the T1D Exchange Clinic Network and registry
Kellee M Miller1, Dongyuan Xing, William V Tamborlane
1Jaeb Center for Health Research, Tampa, FL 33647, USA. T1Dstats@jaeb.org
Abstract:
The T1D Exchange Clinic Network consists of 67 clinics throughout the United States. Among the more than 100,000 patients with type 1 diabetes mellitus (T1DM) who receive care at these centers, more than 26,000 have been enrolled in a registry. The registry includes participants over a wide age range, from age <1 to 93 years, and consists of both those newly diagnosed (more than 3000 diagnosed <1 year from the time of enrollment) and those with long-standing diabetes (more than 1000 with T1DM for at least 40 years). Data on diabetes history, insulin administration, diabetes management, monitoring, complications, medical conditions, medications, and laboratory results are collected at enrollment and annually through participant completion of Web-based questionnaires and data extraction from medical records. The clinic registry has provided a rich data set to address important clinical and public health issues, including important observations regarding the current state of treatment of T1DM in diabetes centers in the United States. Challenges encountered during the establishment of the clinic registry include establishment of criteria for a diagnosis of presumed autoimmune T1DM, standardization of data collected across clinics, data quality, and understanding of potential bias. Collecting the data and maximizing data quality has required considerable effort. Even with these efforts, certain data elements are difficult to capture in a meaningful way. A standard T1DM module used by all electronic health records could be developed based on the data collection instruments developed for the T1D Exchange clinic registry.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes I: Introduction
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Type II Diabetes I: Introduction

